Valeant cuts ties with shadowy pharmacy Philidor

Carly Helfand

is severing all with specialty –which a short seller recently claimed it used to inflate its top line–after reports that altered doctors' orders to squeeze more reimbursement dollars out of insurers. has also informed Valeant that it plans to shut down its operations as soon as possible, the company said.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS